Drug Interaction With Advanced Therapies in Inflammatory Bowel Diseases: A Blind Spot to Tackle.
作者信息
Grellier Nathan, Kirchgesner Julien
机构信息
Department of Gastroenterology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris APHP, Paris, France.
INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, Paris, France.
出版信息
United European Gastroenterol J. 2025 Jun;13(5):663-664. doi: 10.1002/ueg2.12750. Epub 2025 Jan 6.
Abstract
摘要
相似文献
1
Drug Interaction With Advanced Therapies in Inflammatory Bowel Diseases: A Blind Spot to Tackle.炎症性肠病中药物与先进疗法的相互作用：一个有待解决的盲点。
United European Gastroenterol J. 2025 Jun;13(5):663-664. doi: 10.1002/ueg2.12750. Epub 2025 Jan 6.
2
Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis.溃疡性结肠炎患者中埃特拉莫德与阿片类药物或抗抑郁药的联合使用——一项安全性分析。
United European Gastroenterol J. 2025 Jun;13(5):719-727. doi: 10.1002/ueg2.12745. Epub 2025 Feb 1.
3
Low Incidence of Macular Edema and Other Ocular Events in the Etrasimod Development Program.在etrasimod研发项目中黄斑水肿及其他眼部事件的低发生率
J Crohns Colitis. 2025 May 8;19(5). doi: 10.1093/ecco-jcc/jjae173.
4
Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.依特司莫单抗：用于溃疡性结肠炎治疗的鞘氨醇-1-磷酸受体调节剂。
Ann Pharmacother. 2024 Oct;58(10):1054-1063. doi: 10.1177/10600280231225770. Epub 2024 Jan 23.
5
Etrasimod for the treatment of ulcerative colitis.依特司莫单抗治疗溃疡性结肠炎。
Immunotherapy. 2023 Apr;15(5):311-321. doi: 10.2217/imt-2022-0255. Epub 2023 Feb 15.
6
Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): a double-blind, placebo-controlled, randomised, phase 2 trial.艾曲莫德治疗嗜酸性粒细胞性食管炎（VOYAGE）：一项双盲、安慰剂对照、随机、2期试验。
Lancet Gastroenterol Hepatol. 2025 Jul;10(7):622-633. doi: 10.1016/S2468-1253(25)00062-7. Epub 2025 May 14.
7
Sphingosine-1-Phosphate Receptor Modulators for the Treatment of Ulcerative Colitis: A Narrative Review Focusing on Safety.用于治疗溃疡性结肠炎的鞘氨醇-1-磷酸受体调节剂：聚焦安全性的叙述性综述
United European Gastroenterol J. 2025 Sep;13(7):1077-1091. doi: 10.1002/ueg2.70026. Epub 2025 Jun 8.
8
Etrasimod: Modulating Sphingosine-1-Phosphate Receptors to Treat Ulcerative Colitis.艾曲莫德：调节1-磷酸鞘氨醇受体以治疗溃疡性结肠炎。
J Clin Med. 2025 Jun 1;14(11):3890. doi: 10.3390/jcm14113890.
9
Modulation of sphingosine-1-phosphate in inflammatory bowel disease.鞘氨醇-1-磷酸在炎症性肠病中的调控。
Autoimmun Rev. 2017 May;16(5):495-503. doi: 10.1016/j.autrev.2017.03.007. Epub 2017 Mar 7.
10
The Current Sphingosine 1 Phosphate Receptor Modulators in the Management of Ulcerative Colitis.目前用于治疗溃疡性结肠炎的1-磷酸鞘氨醇受体调节剂
J Clin Med. 2025 May 15;14(10):3475. doi: 10.3390/jcm14103475.
本文引用的文献
1
Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis.溃疡性结肠炎患者中埃特拉莫德与阿片类药物或抗抑郁药的联合使用——一项安全性分析。
United European Gastroenterol J. 2025 Jun;13(5):719-727. doi: 10.1002/ueg2.12745. Epub 2025 Feb 1.
2
Concomitant Administration of Ozanimod and Serotonergic Antidepressants in Patients With Ulcerative Colitis or Relapsing Multiple Sclerosis.溃疡性结肠炎或复发型多发性硬化症患者中奥扎莫德与5-羟色胺能抗抑郁药的联合使用
Inflamm Bowel Dis. 2025 Apr 10;31(4):1010-1017. doi: 10.1093/ibd/izae136.
3
Clinician's Guide to Using Ozanimod for the Treatment of Ulcerative Colitis.临床医生使用奥扎莫德治疗溃疡性结肠炎指南。
J Crohns Colitis. 2023 Dec 30;17(12):2012-2025. doi: 10.1093/ecco-jcc/jjad112.
4
Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative Metabolism.依特司莫在健康受试者中的处置和物质平衡，以及体外鉴定其氧化代谢的相关酶。
Clin Pharmacol Drug Dev. 2023 Jun;12(6):553-571. doi: 10.1002/cpdd.1255. Epub 2023 May 3.
5
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.埃特拉莫德用于溃疡性结肠炎的诱导和维持治疗（ELEVATE）：两项随机、双盲、安慰剂对照的3期研究。
Lancet. 2023 Apr 8;401(10383):1159-1171. doi: 10.1016/S0140-6736(23)00061-2. Epub 2023 Mar 2.
6
Landscape of new drugs and targets in inflammatory bowel disease.炎症性肠病新药和新靶点的研究进展。
United European Gastroenterol J. 2022 Dec;10(10):1129-1166. doi: 10.1002/ueg2.12305. Epub 2022 Sep 16.
7
Progressive multifocal leukoencephalopathy and sphingosine 1-phosphate receptor modulators used in multiple sclerosis: an updated review of literature.进行性多灶性白质脑病与多发性硬化中使用的鞘氨醇 1-磷酸受体调节剂：文献更新综述。
J Neurol. 2022 Mar;269(3):1678-1687. doi: 10.1007/s00415-021-10910-1. Epub 2021 Nov 20.
8
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.奥扎莫德用于溃疡性结肠炎的诱导缓解和维持治疗。
N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617.
9
Association between antidepressant medication use and steroid dependency in patients with ulcerative colitis: a population-based study.溃疡性结肠炎患者使用抗抑郁药物与类固醇依赖之间的关联：一项基于人群的研究。
BMJ Open Gastroenterol. 2021 May;8(1). doi: 10.1136/bmjgast-2020-000588.
10
Opioid Use Among Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.炎症性肠病患者的阿片类药物使用：一项系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2021 May;19(5):895-907.e4. doi: 10.1016/j.cgh.2020.08.041. Epub 2020 Aug 21.
Zotero 插件